Garry Boswell

930 total citations
25 papers, 744 citations indexed

About

Garry Boswell is a scholar working on Molecular Biology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Garry Boswell has authored 25 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Garry Boswell's work include Antifungal resistance and susceptibility (5 papers), Cancer therapeutics and mechanisms (4 papers) and Hemoglobin structure and function (3 papers). Garry Boswell is often cited by papers focused on Antifungal resistance and susceptibility (5 papers), Cancer therapeutics and mechanisms (4 papers) and Hemoglobin structure and function (3 papers). Garry Boswell collaborates with scholars based in United States, Japan and India. Garry Boswell's co-authors include Donald N. Buell, I Bekersky, Ihor Bekersky, Thomas J. Walsh, Robert M. Fielding, Ala M. Alak, Maureen McEvoy, Corina Gonzalez, Paul Jarosinski and Vijay Yeldandi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, American Journal of Obstetrics and Gynecology and Pharmaceutical Research.

In The Last Decade

Garry Boswell

25 papers receiving 707 citations

Peers

Garry Boswell

EPIDE

PHARM

PPCH

Patty Fan‐Havard United States

P. L. Meenhorst Netherlands

R E Garner United States

Kuldeep Sharma India

Jodi M. Lestner United Kingdom

Véronique Joly France

Lily Lee United States

Pierre Comby France

S. James Matthews United States

Darren Moss United Kingdom

Patty Fan‐Havard United States

Garry Boswell

438 ×1.4

406 ×1.8

EPIDE

182 ×1.4

130 ×1.6

PHARM

63 ×0.8

PPCH

Citations per year, relative to Garry Boswell Garry Boswell (= 1×) peers Patty Fan‐Havard

Countries citing papers authored by Garry Boswell

Since Specialization

Citations

This map shows the geographic impact of Garry Boswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Boswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Boswell more than expected).

Fields of papers citing papers by Garry Boswell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Boswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Boswell. The network helps show where Garry Boswell may publish in the future.

Co-authorship network of co-authors of Garry Boswell

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Boswell. A scholar is included among the top collaborators of Garry Boswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Boswell. Garry Boswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brandt, Christopher P., et al.. (2011). Fatty liver disease is associated with underlying cardiovascular disease in HIV-infected persons*. HIV Medicine. 12(8). 463–471. 31 indexed citations

Miles, Dale, et al.. (2006). Validation and use of three complementary analytical methods (LC–FLS, LC–MS/MS and ICP–MS) to evaluate the pharmacokinetics, biodistribution and stability of motexafin gadolinium in plasma and tissues. Analytical and Bioanalytical Chemistry. 385(2). 345–356. 16 indexed citations

Mani, Chitra, et al.. (2005). Reductase‐mediated metabolism of motexafin gadolinium (Xcytrin®) in rat and human liver subcellular fractions and purified enzyme preparations. Journal of Pharmaceutical Sciences. 94(3). 559–570. 6 indexed citations

Miles, Dale, Jennifer A. Smith, See‐Chun Phan, et al.. (2005). Population Pharmacokinetics of Motexafin Gadolinium in Adults With Brain Metastases or Glioblastoma Multiforme. The Journal of Clinical Pharmacology. 45(3). 299–312. 10 indexed citations

Naumovski, Louie, Jason Ramos, Mint Sirisawad, et al.. (2005). Sapphyrins induce apoptosis in hematopoietic tumor–derived cell lines and show in vivo antitumor activity. Molecular Cancer Therapeutics. 4(6). 968–976. 35 indexed citations

Pirsch, John D., Ihor Bekersky, Flavio Vincenti, et al.. (2000). Coadministration of Tacrolimus and Mycophenolate Mofetil in Stable Kidney Transplant Patients: Pharmacokinetics and Tolerability. The Journal of Clinical Pharmacology. 40(5). 527–532. 32 indexed citations

Kimanani, Ebi K., Daria Stypinski, Mark R. Stiles, et al.. (2000). A Contract Research Organization's Response to the New FDA Guidances for Bioequivalence/Bioavailability Studies for Orally Administered Drug Products. The Journal of Clinical Pharmacology. 40(10). 1102–1108. 35 indexed citations

Bekersky, Ihor, et al.. (2000). Safety, Toxicokinetics and Tissue Distribution of Long-Term Intravenous Liposomal Amphotericin B (ambisome®): A 91-day Study in Rats. Pharmaceutical Research. 17(12). 1494–1502. 49 indexed citations

Bekersky, Ihor, et al.. (1999). Safety and Toxicokinetics of Intravenous Liposomal Amphotericin B (AmBisome ®) in Beagle Dogs. Pharmaceutical Research. 16(11). 1694–1701. 48 indexed citations

10.

Boswell, Garry, Donald N. Buell, & I Bekersky. (1998). AmBisome (Liposomal Amphotericin B): A Comparative Review. The Journal of Clinical Pharmacology. 38(7). 583–592. 174 indexed citations

11.

Walsh, Thomas J., Vijay Yeldandi, Maureen McEvoy, et al.. (1998). Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients. Antimicrobial Agents and Chemotherapy. 42(9). 2391–2398. 139 indexed citations

12.

Boswell, Garry, et al.. (1998). Toxicological Profile and Pharmacokinetics of a Unilamellar Liposomal Vesicle Formulation of Amphotericin B in Rats. Antimicrobial Agents and Chemotherapy. 42(2). 263–268. 66 indexed citations

13.

Boswell, Garry, Ihor Bekersky, Qais Mekki, & James C. Eisenach. (1997). Plasma concentrations and disposition of clonidine following a constant 14-day epidural infusion in cancer patients. Clinical Therapeutics. 19(5). 1024–1030. 7 indexed citations

14.

Wingard, John R., RA Nash, Voravit Ratanatharathorn, et al.. (1997). Lack of interaction between tacrolimus (FK506) and methotrexate in bone marrow transplant recipients. Bone Marrow Transplantation. 20(1). 49–51. 7 indexed citations

15.

Baysinger, Curtis L., et al.. (1992). Possible Intraoperative Anesthetic-Sparing Effect of Parenteral Ketorolac. Annals of Pharmacotherapy. 26(7-8). 922–924. 12 indexed citations

16.

Tillotson, Jerry Ann, et al.. (1989). The Biological Fate of 14C-Dimercaptosuccinic Acid in Monkeys and Rabbits. Military Medicine. 154(9). 444–449. 6 indexed citations

17.

Moore, Gerald L., et al.. (1988). Toxicity and clearance of sodium phosphate intravenously injected into rabbits.. PubMed. 153(4). 203–6. 2 indexed citations

18.

Marks, Donald H., Gerald L. Moore, F. Medina, et al.. (1988). Optimization of Synthesis of Pyridoxalated Polymerized Stroma-free Hemoglobin Solution. Military Medicine. 153(1). 44–49. 12 indexed citations

19.

Boswell, Garry, et al.. (1988). Exogenous Methemoglobin as a Cyanide Antidote in Rats. Pharmaceutical Research. 5(12). 749–752. 4 indexed citations

20.

Boswell, Garry & Jordan L. Cohen. (1982). GC Analysis of Imidazopyrazole in Plasma Using Nitrogen-Specific Detection. Journal of Pharmaceutical Sciences. 71(9). 1055–1057. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact